News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

10/14/2021 | Ovesco Endoscopy AG

OTSC® vs surgery in scope-induced duodenal perforations: Retrospective comparison study shows superiority of the OTSC regarding morbidity and mortality

The retrospective analysis included overall 20 patients with type I duodenal perforation. 8 patients were treated with OTSC and 12 by surgery. Baseline parameters and per...
10/12/2021 | CureVac AG

CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology

COVID-19 vaccine efforts to be re-allocated to accelerate the development of second-generation program in collaboration with GSK First-generation vaccine candidate, ...
09/28/2021 | Insilico Biotechnology AG

Prof. René Schenkendorf joins Insilico Biotechnology AG Scientific Advisory Board

(Stuttgart) - Insilico Biotechnology AG has announced that Prof. Dr.-Ing. René Schenkendorf has complemented its Scientific Advisory Board. With this further expansion of...
09/14/2021 | CureVac AG

CureVac Streamlines European Network for mRNA Product Manufacturing

CureVac right-sizes manufacturing network to adapt to changes in vaccine peak demands Demand reassessed for first-generation COVID-19 vaccine candidate, CVnCoV, currently under regulatory review ...
Aktuelles_UniTübingen_Mikroskopie
09/09/2021 | Eberhard Karls Universität Tübingen

Machine learning improves biological image analysis

Machine learning improves biological image analysis. International team of researchers develops algorithm that accelerates super-resolution microscopy.Scientists use super-resolution microscopy to stu...
Termin_BSTART
09/02/2021 | BioRegio STERN Management GmbH

Solutions for Digital Health Applications

What is blockchain technology and how can it be implemented in the healthcare, logistics and agrofood sectors? Many companies are not aware of the advantages of blockchain technology. To find out the extent to which this technology offers advant...
Aktuelles_Klinikum Tübingen_Epilepsie
09/01/2021 | Universitätsklinikum Tübingen

First specific drug therapy for a severe early form of epilepsy

Epilepsy comes in a variety of forms. Those affected by a genetically determined variety have severe epileptic seizures as early as the first year of life. The disease is accompanied by severe develop...
09/01/2021 | Ovesco Endoscopy AG

HemoPill® acute: multicentric retrospective study shows promising results in clinical routine

The use of the HemoPill acute demonstrated its ability to reliably detect or exclude bleeding in the upper gastrointestinal tract. ...
08/30/2021 | CureVac AG

CureVac Preclinical Data Demonstrates Significant Reduction of Liver Fibrosis with mRNA Therapeutic

Findings in preclinical mouse models provide first direct proof of efficacy of HNF4A mRNA therapeutics in the treatment of liver fibrosis and cirrhosis Further resea...
Entry of a Cave and people sitting in front of it
08/25/2021 | Eberhard Karls Universität Tübingen

Oldest genome from Wallacea shows previously unknown ancient human relations

The oldest genome of a modern human from the Wallacea region – the islands between western Indonesia and Papua New Guinea – indicates a previously undescribed ancient hum...
Two PC-Screens with a Keyboard on a desk
08/24/2021 | Insilico Biotechnology AG

Insilico Biotechnology AG participates in Inno4vac, a European new public-private partnership to innovate vaccine development

(Stuttgart) - The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 33 million to support Inno4vac, an innovative public-private partnershi...
08/16/2021 | CureVac AG

Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study

Preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone jointly developed by CureVac and GSK compared to CureVa...
08/16/2021 | CureVac AG

CureVac Announces Financial Results for the Second Quarter and First Half of 2021 and Provides Business Update

Continuation of corporate transformation into commercial-ready biopharma company Management team strengthened with appointments of Chief Operating Officer Malte ...
08/12/2021 | Ovesco Endoscopy AG

FTRD®: hybrid technique combining EMR and EFTR permits resection of large polyps

65 consecutive patients underwent EFTR of colorectal lesions, either via stand-alone EFTR (lesions <2 cm in size but not amenable to standard EMR; n = 38 lesions) or h...
08/10/2021 | HepaRegeniX

HepaRegeniX initiates first-in-man Phase 1 trial for its lead MKK4 inhibitor HRX‑0215

Tubingen (Germany), August 10, 2021 – HepaRegeniX GmbH, a clinical stage company developing novel therapies for the treatment of acute and chronic liver diseases, announc...
08/03/2021 | Eberhard Karls Universität Tübingen

Study tracks global death toll of COVID-19 pandemic

Using the World Mortality Dataset, the largest existing collection of mortality data, researchers of the University of Tübingen and the Hebrew University of Jerusalem have tracked the impact of COVID-...
07/28/2021 | Insilico Biotechnology AG

Prominent Scientist Professor John Bagterp Jørgensen joins Insilico Scientific Advisory Board

(Stuttgart) - Insilico Biotechnology AG announces that Professor John Bagterp Jørgensen is joining its Scientific Advisory Board to enrich the scientific capabilities of ...
Aktuelles_Ensinger_Nufringen_EN
07/22/2021 | Ensinger GmbH

Ensinger presents climate strategy

The manufacturing sector – particularly the plastics industry – has a key part to play in curbing climate change. With this in mind, the Ensinger Group’s owners and management team are acknowledging their responsibility when it comes to limiting...
07/20/2021 | Ovesco Endoscopy AG

BougieCap®: significant symptomatic improvement of esophageal strictures achieved by a single bougienage in patients with eosinophilic esophagitis

A cohort study of 50 patients with symptomatic eosinophilic esophagitis treated with a single dilation session using the BougieCap showed 100 % technical success, a drop ...
07/08/2021 | Ovesco Endoscopy AG

HemoPill® acute shows promising results in a non-fasting patient with a mid-gastrointestinal bleeding: a case report

Ovesco’s first wireless sensor capsule for detection of upper and middle gastrointestinal (GI) bleeding was successfully used in a patient with a bleeding caused by Mecke...
Load more